Cross-priming is under control of the relB gene.

Castiglioni, P; Janssen, E M; Prilliman, K R; Gerloni, M; Schoenberger, S; Zanetti, M

Castiglioni, P; Janssen, E M; Prilliman, K R; Gerloni, M; Schoenberger, S; Zanetti, M.

Affiliation

Castiglioni P; Department of Medicine and Cancer Center, University of California, San Diego, La Jolla 92093-0837, USA.

Scand J Immunol ; 56(3): 219-23, 2002 Sep.

Article in En | MEDLINE | ID: mdl-12193222

Subject(s)

Antigen Presentation; Proto-Oncogene Proteins/physiology; T-Lymphocytes, Cytotoxic/immunology; Transcription Factors/physiology; Animals; Antigens/immunology; Antigens/metabolism; Bone Marrow Transplantation; Cells, Cultured; Cytotoxicity Tests, Immunologic; Langerhans Cells/immunology; Lymph Nodes/immunology; Lymphocyte Activation; Mice; Mice, Inbred C57BL; Mice, Knockout; Protein Transport; Proto-Oncogene Proteins/genetics; Spleen/cytology; Spleen/immunology; Transcription Factor RelB; Transcription Factors/genetics; Transplantation Chimera

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Transcription Factors / T-Lymphocytes, Cytotoxic / Proto-Oncogene Proteins / Antigen Presentation Type of study: Prognostic_studies Limits: Animals Language: En Journal: Scand J Immunol Year: 2002 Document type: Article Affiliation country: United States Country of publication: United kingdom

Search on Google

Add to My VHL

XML

PubMed Links